Renaissance Technologies’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
FLAM
GPP
RSCM
Renaissance Technologies's XENT Position: Q1 2021 in Review
Renaissance Technologies sold out of Intersect ENT, Inc (XENT) in Q1 2021, closing a stake of 52,315 shares — an estimated $1.2M sold.
Renaissance Technologies first reported a position in XENT in Q1 2015 and held it in 16 quarters. The position peaked at $17.6M in Q1 2018. 108 funds tracked by Wall St. Rank hold XENT as of Q1 2021.
- Renaissance Technologies reported no remaining Intersect ENT, Inc position as of Q1 2021 after selling out during the quarter.
- Renaissance Technologies sold 52,315 Intersect ENT, Inc shares in Q1 2021, an estimated $1.2M.
- Renaissance Technologies first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 16 quarters.
- Renaissance Technologies's Intersect ENT, Inc position peaked at $17.6M in Q1 2018.
- 108 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2021.
Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.